Fast Locator 2011-2012: MPI Research - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: MPI Research



MPI RESEARCH – Your Responsive CRO

MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Responsiveness, scientific knowledge, and experience, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization.

Our open and responsive culture is evident in the collegial, collaborative atmosphere at MPI Research. Sponsors find communication with their counterparts within the company to be refreshingly easy, frequent, and informative. Study Directors are uniquely accessible on a real-time basis and proactive in keeping you informed as developments unfold, from collaboration on the initial program design through final report.

A Full Spectrum of Integrated Services
MPI Research has conducted thousands of drug safety, discovery, and bioanalytical and analytical studies. The company’s internal structure allows us to respond and adapt rapidly, from making last minute scheduling changes to developing new capabilities as needed. We test a wide and diverse range of compound classes, provide all routes of administration with the exception of inhalation, and offer studies with numerous species and models. With ample physical and technical capacity, we can accommodate multiple requirements simultaneously, adjust schedules readily, and produce results quickly.

Biologic Expertise
MPI Research built its reputation on its toxicological experience and knowledge with small molecules. However, the company is ahead of the curve in responding to recent market trends with biopharmaceuticals. Our scientific experts understand the many significant ways in which the development process of a large molecule differs from that of traditional small molecules, including immune response, dose solution preparatory considerations, species-specific pharmacologic factors, and delivery methods. MPI Research has the experience and knowledge to meet all of your development needs for both large and small molecules.


Regions Where Services are Offered:

North America, Asia, Europe, and key ROW areas.


Outsourcing serivces provided:

Analytical Services

  • Chemistry & stability
  • Bioanalytical testing
  • Biosafety & product characterization
  • Microbiology

Website:

www.mpiresearch.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
75%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced

Click here